The DOI matches its Crossref record.
ENDOGENOUS SEX HORMONE LEVELS IN OLDER ADULT MEN WITH DIABETES MELLITUS
Abstract
In a Southern California population-based cohort of 985 men aged 40-79 years in 1972-1974, 110 men with diabetes had significantly lower mean levels of endogenous plasma testosterone and sex hormone-binding globulin than did 875 nondiabetic men. Mean androstenedione, estrone, and estradiol levels did not differ significantly by diabetic status. The testosterone and sex hormone-binding globulin differences were reduced but not eliminated after adjustment for age and body mass index (weight (kg)/height (m)2). Twenty-one percent of diabetic men compared with 13% of nondiabetic men had testosterone levels below a categorically defined normal level of 3,500 pg/ml. Testosterone was inversely related to degree of glycemia in the whole cohort. Throughout the whole range of plasma glucose, there was a stepwise decrease in mean testosterone levels per categorical increase in fasting plasma glucose, apparent in both diabetics and nondiabetics. The clinical and physiologic implications of the reduced testosterone levels in diabetic men merit further investigation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, it has been reported that testosterone levels are lower in diabetic men compared with nondiabetic subjects (6 -9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [6]
Citations
Cited by
Sorted by citations
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
“Both testosterone and SHBG tend to decrease in elderly men with diabetes mellitus (207).”
BackgroundKapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791
Human prostate cancer risk factors
Bostwick, D. G., BURKE, H. B., Djakiew, D., Euling, S. Y., Ho, S., Landolph, J. R., MORRISON, H. I., Sonawane, B. R., Shifflett, T., Waters, D. J., et al. (2004) · Cancer · doi:10.1002/cncr.20408 · Cited by 675
Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0804 · Cited by 631
Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes
Kapoor, D., Aldred, H., Clark, S., Channer, K. S., & Jones, T. H. (2007) · Diabetes Care · doi:10.2337/dc06-1426 · Cited by 493
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Kasper, J. S., & Giovannucci, E. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0410 · Cited by 491
“Similarly, studies in men show that as blood glucose levels increase, there is also a simultaneous decrease in testosterone levels (55, 56).”
BackgroundType 2 diabetes mellitus and testosterone: a meta-analysis study: Type 2 diabetes and testosterone
Corona, G., Monami, M., Rastrelli, G., Aversa, A., Sforza, A., Lenzi, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01117.x · Cited by 370
Selvin, E., Feinleib, M., Zhang, L., Rohrmann, S., Rifai, N., Nelson, W. G., Dobs, A., Basaria, S., Golden, S. H., & Platz, E. A. (2007) · Diabetes Care · doi:10.2337/dc06-1579 · Cited by 333
Diabetes mellitus and risk of prostate cancer: a meta-analysis
Bonovas, S., Filioussi, K., & Tsantes, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1415-6 · Cited by 332
“Diabetic men have lower total and free testosterone levels [59, 60, 61, 62, 63, 64, 65].”
BackgroundYamamoto, M., Yamaguchi, T., Yamauchi, M., Kaji, H., & Sugimoto, T. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081207 · Cited by 326
“Cross-sectional studies have found that 21–64% of T2DM men have hypogonadism, with higher prevalence rates in the elderly.((34,35)) Recently, large cohort studies showed that T2DM men also had a higher relative risk for hip TABLE 6.”
Backgroundvan de Poll-Franse, L. V., Houterman, S., Janssen-Heijnen, M. L. G., Dercksen, M. W., Coebergh, J. W. W., & Haak, H. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22532 · Cited by 324
Cancer risk in patients with diabetes mellitus
Adami, H., McLaughlin, J. K., Ekbom, A., Berne, C., Silverman, D. T., Hacker, D. G., & Persson, I. (1991) · Cancer Causes & Control · doi:10.1007/bf00051670 · Cited by 319
Androgens, insulin resistance and vascular disease in men
Kapoor, D., Malkin, C. J., Channer, K. S., & Jones, T. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02299.x · Cited by 317
The Metabolic Syndrome and Male Infertility
Kasturi, S. S., Tannir, J. R., & Brannigan, R. E. (2008) · Journal of Andrology · doi:10.2164/jandrol.107.003731 · Cited by 306
Prostate Cancer Risk and Serum Levels of Insulin and Leptin: a Population-Based Study
Hsing, A. W., Chua, S. C., Gao, Y., Gentzschein, E., Chang, L. J., Deng, J., & Stanczyk, F. Z. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.10.783 · Cited by 295
Barrett-Connor, E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-807 · Cited by 281
“As reviewed elsewhere (1), studies in animals show reduced Leydig cell number and testosterone levels, but studies in humans are contradictory.”
BackgroundSelf-citationLower endogenous androgens predict central adiposity in men
Khaw, K., & Barrett-Connor, E. L. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90012-f · Cited by 247
Self-citationZitzmann, M., & Nieschlag, E. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440183 · Cited by 248
Kapoor, D., Clarke, S., Stanworth, R. D., Channer, K. S., & Jones, T. H. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0737 · Cited by 234
Obesity and cancer pathogenesis
Berger, N. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12416 · Cited by 241
Gonadal dysfunction in systemic diseases
Karagiannis, A. I., & Harsoulis, F. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01886 · Cited by 230
Moayeri, A., Mohamadpour, M., Mousavi, S., Shirzadpour, E., Mohamadpour, S., & Amraei, M. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s131945 · Cited by 228
“Some studies have found that 21%–64% of T2DM men have hypogonadism, with higher prevalence rates in the elderly.(53,54) Thus, we can say that the presence of DM may cause hypogonadism and may be one of the risk factors of secondary osteoporosis, especially in elderly men.”
Smith, K. W., Feldman, H. A., & McKinlay, J. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01152.x · Cited by 203
Goodman‐Gruen, D., & Barrett-Connor, E. L. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.912 · Cited by 202
Self-citationSex Differences in Osteoporosis in Older Adults With Non—Insulin-Dependent Diabetes Mellitus
Barrett-Connor, E. L. (1992) · JAMA · doi:10.1001/jama.1992.03490230063029 · Cited by 199
Self-citationSex Steroid Hormones, Upper Body Obesity, and Insulin Resistance
Abate, N., Haffner, S. M., Garg, A., Peshock, R. M., & Grundy, S. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020567 · Cited by 187
Declining gonadal function in elderly men
Kaufman, J. M., & Vermeulen, A. (1997) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(97)80302-3 · Cited by 181
on behalf of the Diabetes and Cancer Research Consortium, Carstensen, B., Read, S. H., Friis, S., Sund, R., Keskimäki, I., Svensson, A.-M., Ljung, R., Wild, S. H., Kerssens, J. J., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3884-9 · Cited by 180
“were previously shown to lead to an increased risk of prostate cancer [33], while hyperglycaemia has also been shown to inhibit testosterone production [34].”
BackgroundEndocrinology of the aging male
de Araújo, A. B., & Wittert, G. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.11.004 · Cited by 184
Diabetes mellitus and risk of prostate cancer in the health professionals follow‐up study
Kasper, J. S., Liu, Y., & Giovannucci, E. L. (2008) · International Journal of Cancer · doi:10.1002/ijc.24044 · Cited by 181
“Similarly, studies in men show that as blood glucose levels increase, T levels decrease.(38,39)”
ResultAndrogen deficiency, diabetes, and the metabolic syndrome in men
Kalyani, R. R., & Dobs, A. S. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32814db856 · Cited by 173
The Metabolic Syndrome Is Associated with Reduced Risk of Prostate Cancer
Tande, A. J., Platz, E. A., & Folsom, A. R. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj320 · Cited by 164
“Men with diabetes or the metabolic syndrome have been reported to have decreased testosterone levels (23, 24); conversely, men with decreased testosterone levels are at significantly higher risk TABLE 3.”
BackgroundBirkeland, K. I., Hanssen, K. F., Torjesen, P. A., & Vaaler, S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432768 · Cited by 161
Hypogonadotropic Hypogonadism in Men With Diabesity
Dhindsa, S., Ghanim, H., Batra, M., & Dandona, P. (2018) · Diabetes Care · doi:10.2337/dc17-2510 · Cited by 162
“It has been known for over two decades that males with type 2 diabetes frequently have low total testosterone concentrations (6).”
BackgroundInterrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study
Simon, D., Preziosi, P., Barrett-Connor, E., Roger, M., Saint-Paul, M., Nahoul, K., & Papoz, L. (1992) · Diabetologia · doi:10.1007/bf00402551 · Cited by 157
Self-citationDecreased Serum Testosterone in Men With Acute Ischemic Stroke
Jeppesen, L. L., Jørgensen, H. S., Nakayama, H., Raaschou, H. O., Olsen, T. S., & Winther, K. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.6.749 · Cited by 148
Diabetes mellitus and risk of prostate cancer (United States)
Giovannucci, E. L., Rimm, E. B., Stampfer, M. J., Colditz, G. A., & Willett, W. C. (1998) · Cancer Causes & Control · doi:10.1023/a:1008822917449 · Cited by 148
“The lower risk of prostate cancer among diabetics might result from lower insulin or insulin-like growth factor I (IGF-1),(8) or reduced total and bioavailable testosterone levels which have been associated with diabetes.(9-15) However, the previous studies have been limited by small numbers,(1-3,5-7) failure to accou…”
BackgroundKhaw, K., & Barrett-Connor, E. L. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.489 · Cited by 142
Self-citationAging and the Male Reproductive System
Kaufman, J., Lapauw, B., Mahmoud, A., T'Sjoen, G. G., & Huhtaniemi, I. T. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00178 · Cited by 150
Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes
Azoulay, L., Dell’Aniello, S., Gagnon, B., Pollak, M., & Suissa, S. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0940 · Cited by 133
“In line with this hypothesis, studies have shown that as blood glucose levels increase, androgen levels decrease in diabetic men (41, 42).”
ResultCardiovascular Disease Risk Factors Predict the Development of Type 2 Diabetes
D’Agostino, R. B., Hamman, R. F., Karter, A. J., Mykkänen, L., Wagenknecht, L. E., Haffner, S. M., & for the Insulin Resistance Atherosclerosis Study Investigators (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2234 · Cited by 127
Androgen cell signaling pathways involved in neuroprotective actions
Pike, C. J., Nguyen, T. V., Ramsden, M., Yao, M., Murphy, M. P., & Rosario, E. R. (2007) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.11.006 · Cited by 132
Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity
Phillips, G. B. (1993) · Metabolism · doi:10.1016/0026-0495(93)90181-m · Cited by 116
Seasonal Variation of Testosterone and Waist to Hip Ratio in Men: The Tromsø Study
Svartberg, J. B., Jorde, R., Sundsfjord, J., Bønaa, K. H., & Barrett-Connor, E. L. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021878 · Cited by 114
Self-citationGambineri, A., Pelusi, C., & Pasquali, R. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345209 · Cited by 113
Testosterone and Atherosclerosis in Aging Men
Jones, R. D., Nettleship, J. E., Kapoor, D., Jones, H. T., & Channer, K. S. (2005) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200505030-00001 · Cited by 112
Corrales, J. J., Almeida, M., Burgo, R., Mories, M. T., Miralles, J. M., & Orfao, A. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06779 · Cited by 110
“…of health status (Harman et al. 2001), in diseases such as diabetes mellitus androgen deficiency could be exacerbated since lower testosterone values have been reported in older type-2 diabetic men than in age-matched non-diabetic individuals (Barrett-Connor et al. 1990, Anderson et al. 1994).”
BackgroundCorona, G., Forti, G., & Maggi, M. (2008) · The Aging Male · doi:10.1080/13685530802468497 · Cited by 107
Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study
Murtola, T. J., Tammela, T. L. J., Lahtela, J. T., & Auvinen, A. P. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn190 · Cited by 104
Nuver, J., Smit, A. J., Postma, A., Sleijfer, D. T., & Gietema, J. A. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)00038-5 · Cited by 105
Betancourt-Albrecht, M., & Cunningham, G. R. (2003) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901031 · Cited by 102
Prostate-specific Antigen Values in Diabetic and Nondiabetic US Men, 2001–2002
Werny, D. M., Saraiya, M., & Gregg, E. W. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj311 · Cited by 102
Haring, R., Ittermann, T., Völzke, H., Krebs, A., Zygmunt, M., Felix, S. B., Grabe, H. J., Nauck, M. A., & Wallaschofski, H. (2010) · The Aging Male · doi:10.3109/13685538.2010.487553 · Cited by 101
“Additionally, diabetes also offers potential bidirectional associations as the presence of lower TT levels in men with diabetes is well known [43,44], and low levels of TT were identified to be predictive of diabetes [45].”
BackgroundDiabetes mellitus is associated with subnormal serum levels of free testosterone in men
Rhoden, E. L., Ribeiro, E. P., Teloken, C., & Souto, C. A. V. (2005) · BJU International · doi:10.1111/j.1464-410x.2005.05728.x · Cited by 100
Endogenous sex hormones: Impact on lipids, lipoproteins, and insulin
Haffner, S. M., & Valdez, R. A. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80058-8 · Cited by 101
Diabetes and Cancer—An AACE/ACE Consensus Statement
Handelsman, Y., LeRoith, D., Bloomgarden, Z. T., Dagogo-Jack, S. E., EINHORN, D. F., Garber, A. J., Grunberger, G., Harrell, R. M., Gagel, R. F., Lebovitz, H. E., et al. (2013) · Endocrine Practice · doi:10.4158/ep13248.cs · Cited by 100
“Prostate cancer risk appears to be decreased in patients with diabetes (63); one possible explanation is that testosterone levels have been shown to be reduced in men with diabetes (64).”
BackgroundCorona, G., Mannucci, E., Petrone, L., Schulman, C., Balercia, G., Fisher, A. D., Chiarini, V., Forti, G., & Maggi, M. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00498.x · Cited by 96
Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control
Corrales, J. J., Burgo, R. M., Garcı́a-Berrocal, B., Almeida, M., Alberca, I., González-Buitrago, J. M., Orfao, A., & Miralles, J. M. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.016 · Cited by 97
Kaufman, J., & Vermeulen, A. (1998) · Springer eBooks · doi:10.1007/978-3-642-72185-4_16 · Cited by 92
The many faces of testosterone
Bain, J. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1417 · Cited by 90
Kapoor, D., Clarke, S., Channer, K. S., & Jones, T. H. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00744.x · Cited by 90
Insights into the relationships between diabetes, prediabetes, and cancer
Scappaticcio, L., Maiorino, M. I., Bellastella, G., Giugliano, D., & Esposito, K. (2016) · Endocrine · doi:10.1007/s12020-016-1216-y · Cited by 89
“Furthermore, the lower testosterone levels found in men with diabetes, obesity or both [24], and the evidence that hyperglycemia inhibits testosterone secretion [61], may”
BackgroundSexual dysfunction in men with type 2 diabetes
Isidro, M. L. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-130069 · Cited by 86
Testosterone and Coronary Artery Disease
Nettleship, J. E., Jones, R. D., Channer, K. S., & Jones, T. H. (2008) · Frontiers of hormone research · doi:10.1159/000176047 · Cited by 90
Male andropause: myth, reality, and treatment
Wespes, E., & Schulman, C. C. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900798 · Cited by 83
Sex hormones, obesity and type 2 diabetes: is there a link?
Gambineri, A., & Pelusi, C. (2018) · Endocrine Connections · doi:10.1530/ec-18-0450 · Cited by 82
Testosterone Associations with Erectile Dysfunction, Diabetes, and the Metabolic Syndrome
Jones, T. H. (2007) · European Urology Supplements · doi:10.1016/j.eursup.2007.07.002 · Cited by 76
Testosterone and Erectile Dysfunction
Yassin, A. A., & Saad, F. (2008) · Journal of Andrology · doi:10.2164/jandrol.107.004630 · Cited by 73
The Effects of Metformin and Diet on Plasma Testosterone and Leptin Levels in Obese Men
Özata, M., Öktenli, Ç., Bingöl, N., & Ozdemír, I. C. (2001) · Obesity Research · doi:10.1038/oby.2001.90 · Cited by 71
Variation in TCF7L2 and Increased Risk of Colon Cancer
Folsom, A. R., Pankow, J. S., Peacock, J. M., Bielinski, S. J., HEISS, G. M., & Boerwinkle, E. (2008) · Diabetes Care · doi:10.2337/dc07-2131 · Cited by 75
Sex Hormone-Binding Globulin in Children and Adolescents
Aydın, B. K., & Winters, S. J. (2016) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.2764 · Cited by 70
“Sorensen et al (112) found that, after adjustment for BMI and pubertal stage, girls with central precocious puberty have lower SHBG levels compared with healthy controls, and the decline in SHBG levels during puberty is associated with increasing fat mass in healthy children and adolescents.”
BackgroundInfluentialSex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development
(2017) · EndocrinologyJN · doi:10.1210/en.2016-1668 · Cited by 71
Hypogonadism and erectile dysfunction: the role for testosterone therapy
Shabsigh, R. (2003) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901030 · Cited by 69
Androgens, Aging, and Alzheimer's Disease
Pike, C. J., Rosario, E. R., & Nguyen, T. V. (2006) · Endocrine · doi:10.1385/endo:29:2:233 · Cited by 66
Tanaka, M., Nakaya, S., Kumai, T., et al. (2001) · Endocrine Research · doi:10.1081/erc-100107174 · Cited by 62
“In men with DM, relatively low serum T levels have also been reported (22).”
BackgroundLow testosterone and anaemia in men with type 2 diabetes
Grossmann, M., Panagiotopolous, S., Sharpe, K., MacIsaac, R. J., Clarke, S., Zajac, J. D., Jerums, G., & Thomas, M. C. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03357.x · Cited by 60
Kapoor, D., Channer, K. S., & Jones, T. H. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.022 · Cited by 58
Hormonal profile of diabetic men and the potential link to prostate cancer
Kasper, J. S., Liu, Y., Pollak, M., et al. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9133-x · Cited by 58
“Similarly, studies in men show that as blood glucose levels increase, T levels decrease [35, 36].”
ResultBrand, J. S., Wareham, N. J., Dowsett, M., Folkerd, E. J., van der Schouw, Y. T., Luben, R., & Khaw, K. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03951.x · Cited by 55
Self-citationAndrogen Deficiency as a Predictor of Metabolic Syndrome in Aging Men
Kapoor, D., & Jones, T. H. (2008) · Drugs & Aging · doi:10.2165/00002512-200825050-00001 · Cited by 52
Schipf, S., Haring, R., Friedrich, N., Nauck, M. A., Lau, K., Alte, D., Stang, A., Völzke, H., & Wallaschofski, H. (2010) · The Aging Male · doi:10.3109/13685538.2010.524955 · Cited by 52
Katsuki, A., Sumida, Y., Murashima, S., Fujii, M., Ito, K., Tsuchihashi, K., Murata, K., Yano, Y., & Shima, T. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.7.8675570 · Cited by 55
Mechanisms of obesity-induced male infertility
Phillips, K. P., & Tanphaichitr, N. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.65 · Cited by 51
The Endocrine System in Diabetes Mellitus
Alrefai, H., Allababidi, H., Levy, S., & Levy, J. (2002) · Endocrine · doi:10.1385/endo:18:2:105 · Cited by 52
Postload plasma glucose concentration and 27-year prostate cancer mortality (United States)
Gapstur, S. M., Gann, P. H., Colangelo, L. A., Barron-Simpson, R., Kopp, P. A., Dyer, A. R., & Liu, K. (2001) · Cancer Causes & Control · doi:10.1023/a:1011279907108 · Cited by 47
Han, J. H., Choi, N. Y., Bang, S. H., et al. (2008) · Urology · doi:10.1016/j.urology.2008.01.084 · Cited by 47
Testosterone for secondary prevention in men with ischaemic heart disease?
Malkin, C. J., Pugh, P. J., Jones, T. H., & Channer, K. S. (2003) · QJM · doi:10.1093/qjmed/hcg086 · Cited by 45
Low Testosterone and the Association With Type 2 Diabetes
Farrell, J. A. B., Deshmukh, A., & Baghaie, A. A. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721708323100 · Cited by 39
“It remains unclear whether decreased testosterone levels are related to aging or to diabetes and its complications.(9-25,28) Low Testosterone and Type 2 Diabetes”
BackgroundSex Hormones and Bariatric Surgery in Men
Rao, S. R., Kini, S. U., & Tamler, R. (2011) · Gender Medicine · doi:10.1016/j.genm.2011.05.007 · Cited by 41
Hypogonadotrophic hypogonadism in type 2 diabetes
Dandona, P., Dhindsa, S., Chaudhuri, A., Bhatia, V., & Topiwala, S. (2008) · The Aging Male · doi:10.1080/13685530802317934 · Cited by 38
“T2D men have even lower SHBG levels as compared to age and BMI matched non-diabetics [2].”
BackgroundResultPrevalence of Hypogonadism in Patients with Type 2 Diabetes Mellitus in an Asian Indian Study Group
Ganesh, H. K., Sarathi, V., George, J., Shivane, V. K., Bandgar, T., Menon, P. S., & Shah, N. S. (2009) · Endocrine Practice · doi:10.4158/ep09035.orr · Cited by 38
Ohta, T., Katsuda, Y., Miyajima, K., Sasase, T., Kimura, S., Tong, B., & Yamada, T. (2014) · Journal of Diabetes Research · doi:10.1155/2014/841957 · Cited by 37
“Both serum testosterone and SHBG levels were significantly lower in males with type 2 diabetes, and increasing insulin resistance was associated with decreased testosterone secretion at the testicular level (Leydig cell) [20, 21].”
BackgroundDerkach, K. V., Bakhtyukov, A. A., Romanova, I. V., Zorina, I. I., Bayunova, L. V., Бондарева, В. М., Morina, I. Y., Roy, V. K., & Shpakov, A. O. (2020) · Andrologia · doi:10.1111/and.13816 · Cited by 36
The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome
Haring, R., Völzke, H., Spielhagen, C., Nauck, M. A., & Wallaschofski, H. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312452965 · Cited by 34
Shin, Y. S., You, J. H., Cha, J. S., & Park, J. K. (2016) · The Aging Male · doi:10.1080/13685538.2016.1229764 · Cited by 35
Type 2 diabetes‐associated androgen alteration in patients with erectile dysfunction
El‐Sakka, A. I., Sayed, H. M., & Tayeb, K. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00815.x · Cited by 35
Jasuja, G. K., Travison, T. G., Davda, M. N., Rose, A. J., Zhang, A., Kushnir, M. M., Rockwood, A. L., Meikle, W. A., Coviello, A. D., D’Agostino, R. B., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2477 · Cited by 32
Tripathy, D., Dhindsa, S., Garg, R., Khaishagi, A., Syed, T., & Dandona, P. (2003) · Metabolic Syndrome and Related Disorders · doi:10.1089/154041903321648270 · Cited by 34
“Two of the studies do not mention gonadotropin concentrations 16,17 ; one reports increased gonadotropin, 7 while the fourth reports normal LH and FSH. 6 The study showing elevated LH and FSH (hypogonadotropic hypogonadism) was from Pakistan and may represent some distinct underlying pathological…”
A closer look at the role of insulin for the regulation of male reproductive function
Oghbaei, H., Fattahi, A., Hamidian, G., Sadigh‐Eteghad, S., Ziaee, M., & Mahmoudi, J. (2020) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2020.113643 · Cited by 41
Chodari, L., Mohammadi, M., Ghorbanzadeh, V., Dariushnejad, H., & Mohaddes, G. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.03.004 · Cited by 32
“A higher prevalence of hypogonadism in men with diabetes has been reported (21).”
Background
Metadata
- Authors
- BARRETT-CONNOR, E., KHAW, K.-T., & YEN, S. S. C.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- BARRETT-CONNOR, E.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-11
- Volume
- 132
- Issue
- 5
- Pages
- 895-901
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W1957056004
- Cited by
- 217
- References
- 0
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 6 · 2018: 6 · 2017: 5 · 2016: 9 · 2015: 10 · 2014: 7 · 2013: 7 · 2012: 7
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl034591-02, 5r01am031801-03)
- National Heart, Lung, and Blood Institute (HL 34591, HV-1-2160-L)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- diabetes mellitus, testosterone, sex hormone-binding globulin, androstenedione, estrone, estradiol, older men, fasting blood glucose, glycemia, body mass index, hypogonadism
- MeSH terms
- Adult, Aged, Blood Glucose, Blood Pressure, Cholesterol, Diabetes Mellitus, Humans, Male, Middle Aged, Sex Hormone-Binding Globulin, Testosterone, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
